lino Biotech is the world´s only provider of Focal Molography an entirely new method for measuring molecular interactions in living cells or crude biological samples. The broadly patented technology offers label-free detection assays while eliminating signal disturbances due to temperature changes or non-specific binding. lino Biotech was incorporated in Zürich, Switzerland, in March 2020 with the aim to make cell therapies more cost effective and accessible for a broader patient population by offering new quality control method that every cell therapy manufacturer can use to improve their production and development process.
17.03.2023
lino Biotech acquired by Miltenyi Biotec (venturelab.swiss)
16.03.2023
Germany-based company acquires lino Biotech (startupticker.ch)
05.10.2022
Venture Leaders Biotech 2022: Captain’s blog by Recolony CEO Ana Montalban-Arques (venturelab.swiss)
16.09.2022
The Venture Leaders Biotech impress international investors and industry leaders in Boston (venturelab.swiss)
02.09.2022
lino Biotech: The Venture Leader Biotech making cell therapies cost effective and accessible (venturelab.swiss)
No milestones
No Jobs
lino Biotech - focal Molography
lino Biotech - 1 min Pitch
Website:
www.lino-biotech.com/
Headquarter:
Zürich
Foundation Date:
March 2020
Technology:
Sectors: